IP Library Granted Patent US 9,844,576
Granted Patent B2
US 9,844,576 · App. 13/904,851 · Granted Dec 19, 2017

Compositions and methods for managing weight

Inventors: Lidia Alfaro Brownell (Tacoma, WA); Byong-Il Choi (Cheongwon-gun, KR); Brandon Corneliusen (Tenino, WA); Mei-Feng Hong (Lacey, WA); Eu-Jin Hyun (Cheonan-si, KR); Qi Jia (Olympia, WA); Ping Jiao (Lacey, WA); Hyun-Jin Kim (Asan-si, KR); Mi-Ran Kim (Cheonan-si, KR); Tae-Woo Kim (Ulsan, KR); Bo-Su Lee (Pohang-si, KR); Young-Chul Lee (Daejeon, KR); Jeong-Bum Nam (Cheongwon-gun, KR); Mesfin Yimam (Kent, WA); Ji-Hye Hwang (Jecheon-si, KR); Mi-Sun Oh (Cheonan-si, KR)
Assignees: Unigen, Inc.; Unigen, Inc.
A61K36/575A61K31/12A61K31/343A61K31/352A61K36/10A61K36/185A61K36/258A61K36/346A61K36/37A61K36/38A61K36/53A61K36/56A61K36/605A61K36/67A61K36/752A61K36/889A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,576
App. No.
13/904,851
Granted
Dec 19, 2017
Kind
B2
Abstract

The present disclosure provides Diels-Alder adducts of chalcone and prenylphenyl moieties capable of modulating the activity of cannabinoid receptors, and to oligomers of flavan-3-ol capable of modulating fat absorption and storage. Such Diels-Alder adducts of chalcone and prenylphenyl moieties or oligomers of flavan-3-ol can optionally be used in combination with other weight management agents, such as anorectic agents, a lipase inhibitors, other cannabinoid receptor modulators, psychotropic agents, insulin sensitizers, stimulants, or satiety agents, as well as to methods of use thereof such as treating or preventing weight gain or obesity, promoting weight loss, appetite suppression, modifying satiety, or the like.

Claims (6)

1. A tablet or capsule pharmaceutical or nutraceutical formulation, comprising a mixture of:

a Morus alba extract with an increased amount of Albanin G, Kuwanon G, Morusin, or any combination thereof, as compared to the amount of Albanin G, Kuwanon G, Morusin, or any combination thereof in unextracted Morus alba ;

a Magnolia officinalis extract with an increased amount of magnolol, honokiol, or both, as compared to the amount of magnolol, honokiol, or both in unextracted Magnolia officinalis;

a Yerba Mate extract with an increased amount of caffeine, dicaffeoylquinic acid, or both as compared to the amount of caffeine, dicaffeoylquinic acid, or both in unextracted Yerba Mate; and

a pharmaceutically or nutraceutically acceptable carrier, diluent, or excipient;

wherein the tablet or capsule comprises about 0.5 weight percent (wt %) to about 90 wt % of active ingredients of the extract mixture.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF MESFIN YIMAM NAME PREVIOUSLY RECORDED ON REEL 031384 FRAME 0562. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF THE ENTIRE RIGHT, TITLE AND INTEREST. Recorded Mar 6, 2014
From: BROWNELL, LIDIA ALFARO; CORNELIUSEN, BRANDON; HONG, MEI-FENG; JIA, QI; JIAO, PING; YIMAM, MESFIN
To: UNIGEN, INC.
Reel/Frame 032399/0743 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2013
From: BROWNELL, LIDIA ALFARO; CORNELIUSEN, BRANDON; HONG, MEI-FENG; JIA, QI; JIAO, PING; YIMAN, MESFIN
To: UNIGEN, INC.
Reel/Frame 031384/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2013
From: CHOI, BYONG-IL; HYUN, EU-JIN; KIM, HYUN-JIN; KIM, MI-RAN; KIM, TAE-WOO; LEE, BO-SU; LEE, YOUNG-CHUL; NAM, JEONG-BUM; HWANG, JI-HYE; OH, MI-SUN
To: UNIGEN, INC.
Reel/Frame 031384/0596 →
Continuity (3)
Provisional Application 61652807 · May 29, 2012
Provisional Application 61783729 · Mar 14, 2013
Related Publication 20140004215A1 · Jan 2, 2014